Kirstin Lees

543 total citations
5 papers, 411 citations indexed

About

Kirstin Lees is a scholar working on Genetics, Epidemiology and Hepatology. According to data from OpenAlex, Kirstin Lees has authored 5 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Epidemiology and 2 papers in Hepatology. Recurrent topics in Kirstin Lees's work include Inflammatory Bowel Disease (5 papers), Microscopic Colitis (4 papers) and Liver Diseases and Immunity (2 papers). Kirstin Lees is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Microscopic Colitis (4 papers) and Liver Diseases and Immunity (2 papers). Kirstin Lees collaborates with scholars based in United States, United Kingdom and Australia. Kirstin Lees's co-authors include Gary R. Lichtenstein, William J. Sandborn, Michael A. Kamm, Raymond E. Joseph, Karen Barrett, Stefan Schreiber, Prabhakar Boddu, Todd Butler, N. B. Gubergrits and M A Kamm and has published in prestigious journals such as Gut, The American Journal of Gastroenterology and Clinical Gastroenterology and Hepatology.

In The Last Decade

Kirstin Lees

5 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kirstin Lees United States 4 397 318 128 104 64 5 411
E. А. Belousova Russia 7 240 0.6× 216 0.7× 95 0.7× 76 0.7× 27 0.4× 36 328
Chyon Yeh United States 5 311 0.8× 265 0.8× 126 1.0× 73 0.7× 38 0.6× 8 368
CS Probert United Kingdom 4 251 0.6× 210 0.7× 107 0.8× 34 0.3× 52 0.8× 9 300
K Grancher United States 7 290 0.7× 192 0.6× 152 1.2× 89 0.9× 18 0.3× 12 345
J Bélaïche Belgium 8 296 0.7× 263 0.8× 136 1.1× 31 0.3× 42 0.7× 20 361
Angeliki Christidou Greece 6 361 0.9× 302 0.9× 137 1.1× 77 0.7× 41 0.6× 12 396
Gavin Barr Australia 9 206 0.5× 177 0.6× 155 1.2× 33 0.3× 60 0.9× 15 315
Pauliina Molander Finland 10 425 1.1× 382 1.2× 182 1.4× 22 0.2× 27 0.4× 20 489
Khadija Chaudrey United States 4 248 0.6× 219 0.7× 102 0.8× 34 0.3× 9 0.1× 15 314
Olufemi Kassim United States 4 208 0.5× 185 0.6× 69 0.5× 45 0.4× 11 0.2× 8 267

Countries citing papers authored by Kirstin Lees

Since Specialization
Citations

This map shows the geographic impact of Kirstin Lees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirstin Lees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirstin Lees more than expected).

Fields of papers citing papers by Kirstin Lees

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirstin Lees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirstin Lees. The network helps show where Kirstin Lees may publish in the future.

Co-authorship network of co-authors of Kirstin Lees

This figure shows the co-authorship network connecting the top 25 collaborators of Kirstin Lees. A scholar is included among the top collaborators of Kirstin Lees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirstin Lees. Kirstin Lees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Hanauer, Stephen B., Gary R. Lichtenstein, Michael A. Kamm, et al.. (2009). MMX Mesalamine for Induction and Maintenance Therapy in Mild-to-Moderate Ulcerative Colitis.. PubMed. 5(7). 494–500. 6 indexed citations
2.
Kamm, Michael A., Gary R. Lichtenstein, William J. Sandborn, et al.. (2008). Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis. Inflammatory Bowel Diseases. 15(1). 1–8. 68 indexed citations
3.
Kamm, M A, Gary R. Lichtenstein, William J. Sandborn, et al.. (2008). Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis. Gut. 57(7). 893–902. 135 indexed citations
4.
Lichtenstein, Gary R., Michael A. Kamm, Prabhakar Boddu, et al.. (2007). Effect of Once- or Twice-Daily MMX Mesalamine (SPD476) for the Induction of Remission of Mild to Moderately Active Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 5(1). 95–102. 201 indexed citations
5.
Lichtenstein, Gary R., Michael A. Kamm, Remo Panaccione, et al.. (2007). The Effect of Prolonged Therapy with MMX™ Mesalamine in Patients with Acute, Mild-to-Moderate Ulcerative Colitis. The American Journal of Gastroenterology. 102. S463–S463. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026